Xponance’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $196K | Buy |
21,916
+6,349
| +41% | +$56.9K | ﹤0.01% | 1335 |
|
|
2025
Q1 | $117K | Buy |
15,567
+671
| +5% | +$5.03K | ﹤0.01% | 1327 |
|
|
2024
Q4 | $112K | Buy |
14,896
+1,242
| +9% | +$9.34K | ﹤0.01% | 1350 |
|
|
2024
Q3 | $104K | Buy |
13,654
+674
| +5% | +$5.12K | ﹤0.01% | 1317 |
|
|
2024
Q2 | $80.2K | Buy |
12,980
+1,505
| +13% | +$9.3K | ﹤0.01% | 1257 |
|
|
2024
Q1 | $58.3K | Buy |
11,475
+94
| +0.8% | +$478 | ﹤0.01% | 1269 |
|
|
2023
Q4 | $68.2K | Buy |
11,381
+182
| +2% | +$1.09K | ﹤0.01% | 1225 |
|
|
2023
Q3 | $79.3K | Buy |
11,199
+105
| +0.9% | +$743 | ﹤0.01% | 1177 |
|
|
2023
Q2 | $78.1K | Buy |
11,094
+487
| +5% | +$3.43K | ﹤0.01% | 1207 |
|
|
2023
Q1 | $88.5K | Hold |
10,607
| – | – | ﹤0.01% | 1164 |
|
|
2022
Q4 | $122K | Buy |
10,607
+163
| +2% | +$1.87K | ﹤0.01% | 1145 |
|
|
2022
Q3 | $132K | Buy |
10,444
+370
| +4% | +$4.68K | ﹤0.01% | 1106 |
|
|
2022
Q2 | $107K | Buy |
+10,074
| New | +$107K | ﹤0.01% | 1124 |
|